Macrolide Resistance in MORDOR I — A Cluster-Randomized Trial in Niger
Macrolide Resistance in MORDOR I — A Cluster-Randomized Trial in Niger
About this item
Full title
Macrolide Resistance in MORDOR I — A Cluster-Randomized Trial in Niger
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
The New England journal of medicine, 2019-06, Vol.380 (23), p.2271-2273
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In MORDOR I, azithromycin decreased mortality in children in Niger. In this report, it is shown that azithromycin also increased antimicrobial resistance to macrolide antibiotics in both the nasopharyngeal and stool flora.
Alternative Titles
Full title
Macrolide Resistance in MORDOR I — A Cluster-Randomized Trial in Niger
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6518950
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6518950
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc1901535
